Tyvaso

treprostinil · United Therapeutics

Drug timelines are a Plus or Pro feature.

27 regulatory and trial events tracked for Tyvaso, covering 2009-07-30 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD [Phase 2]